Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-03-06

Clinical Trial Update: MAGIK for Femoral/Tibial Shaft Fractures [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial named MAGIK for femoral and tibial shaft fractures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MAGIK

Snippet

Sponsor: NYU Langone Health | Conditions: Femoral Shaft Fracture, Tibial Shaft Fracture | Phase 2 | Status: WITHDRAWN